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Abstract. A simple and efficient synthesis of two new hydroximinosteroidal derivatives (11, 13) 
from cholesterol as starting material was described. The cytotoxicity of these compounds, their 
intermediates and two other known hydroximinosteroids were evaluated on human cancer cell 
lines including hepatocellular carcinoma (Hep-G2), cervical cancer (HeLa) and glioblastoma 
(T98G). Compound 13 presented a potent antiproliferative effect to T98G cancer cell at 2.9 M 
of IC50. Our results demonstrated that the compounds with oxime group at C-6 having better 
cytotoxic activity against tested cell lines. Presence of 4,5-double bond or 4,5-epoxide can 
increase cytotoxicity for the 3,6-dihydroximino derivatives. In addition, the antimicrobial assay 
showed that two new oximes 11 and 13 were active against E. coli and S. aureus strain with 
MIC values of 50 g/mL. The active compounds may provide us a clue for a lead structure of 
anticancer and antimicrobial agents. 
Keywords: cholesterol, hydroximinosteroid, HeLa, HepG2, T98G. 
Classification numbers: 1.1.2, 1.2.1. 
1. INTRODUCTION 
 In recent years, marine organisms have been regarded as the sources for natural steroids 
with unusual and interesting functionalities [1]. A variety of natural steroids have been isolated 
from various marine organisms, particularly from sponges and starfish [2]. Among them, 
hydroximinosteroids isolated from marine sponges display a wide range of biological activities 
including antiviral, cytotoxicity and aromatase inhibitory activity [3-5]. Especially, compound 
(6E)-hydroximinocholest-4-en-3-one (1) which was isolated from Cinachyrella alloclada 
 
 
Dinh Thi Ha, Baskar Salvaraja, Lee Jae Wook, Tran Thi Thu Thuy 
 
 
528 
exhibited a strong cytotoxicity against P-388 (murine leukemia), A-549 (human lung 
carcinoma), HT-29 (human colorectal adenocarcinoma) and MEL-28 (human myeloma) cell 
lines with IC50 value ranging between 1.25-2.5 g/mL [3,4]. The synthesis of several steroidal 
oximes containing 1-2 hydroximino groups and different side chains has been reported recently. 
Structure – bioactivity relationship studies indicated that the position of hydroximino groups and 
side chain type play a critical role in their cytotoxicities [5-8]. Cytotoxicity assays against P388, 
A549, HT29, MEL28 and T98G cell lines showed that cholestane-type side chain at C-17 
exhibited stronger cytotoxicity compared to sitostane-, stigmastane- or gorgostane-type side 
chain [6, 7].  Presence of oxime group at C-3 or/and C-6 or presence of oxygen on A-ring (C-
3,4,5) could remarkably increase the cytotoxic activity (compounds 2-4) [8,9].  
 
Figure 1. Natural hydroximinosteroid (1) and bioactive synthetic hydroximinosteroids (2-4). 
In this study, we report a short and efficient synthetic pathway for the preparation of two 
new steroidal oximes 11 and 13 from cholesterol as starting material with hydroximino groups at 
C-3 or C-3/C-6 and with epoxide ring at C-4,5. The antiproliferative activity against three 
human cancer cell lines (Hep-G2, HeLa, T98G) as well as the antimicrobial activity against 8 
bacterial and fungal strains of these steroidal oximes and all intermediates were evaluated. In 
order to establish structure/activity relationship, the cytotoxicity of compounds 11 and 13 was 
compared with compounds 3 and 4 from the same bioassay. The aim of this study was to obtain 
additional information about structure-activity relationships for this type of compound.  
2. MATERIALS AND METHODS 
General: All reagents and solvents were purchased from Sigma-Aldrich, Acros and Merck Co 
and used without pre-purification. 
1
H and 
13
C NMR spectra were recorded on a Bruker AV 500 
spectrometer(Germany) at working frequencies 500 and 125 MHz, respectively. Chemical shifts 
() are reported in ppm and coupling constants (J) are given in Hertz (Hz). MS spectra and 
HPLC were recorded on a LC-MS Agilent 1100 (USA). All reactions were monitored by thin 
layer chromatography (TLC) using silica gel 60 coated plates F254 (Merck). Visualization was 
performed under UV lamp at 254 and 365 nm or by spraying with 10 % H2SO4 solution.  
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Antimicrobial activity: Antimicrobial activity assay was performed on a 96-well microplate to 
determine the minimum inhibitory concentration (MIC) against 8 fungal and bacterial strains, 
i.e. Gram-negative bacteria (Escherichia coli M42, Pseudomonas aeruginosa ATCC 25923), 
Gram-positive bacteria (Bacillus subtilis ATCC27212, Staphylococcus aureus ATCC12222). 
The fresh microorganisms were diluted with the growth medium broth to a final inoculum size 
of about 10
5
 colony-forming units (CFU) per mL. The samples were dissolved in 5 % DMSO at 
various concentrations and then were loaded into 96-well microplates with test microorganisms. 
Doxycycline, gentamicin, and nystatin were used as positive references for bacteria, and fungi, 
respectively. A blank control was treated in the same way using 5 % DMSO instead of the test 
samples [10]. 
Cytotoxicity assays: The cytotoxicity on hepatocellular carcinoma (Hep-G2) and cervical cancer 
(HeLa) cell lines was tested at Institute of Natural Products Chemistry (VAST). Cancer cells 
lines, i.e. Hep-G2 and HeLa, were purchased from American Type Culture Collection (ATCC, 
USA) and cultured in DMEM (Dulbecco’s Modified Eagle Medium) or EMEM (Eagle’s 
Minimum Essential Medium, Sigma-Aldrich, Singapore), 10 % heat-inactivated fetal bovine 
serum (FBS), at 37 °C in a humidified atmosphere of 95 % air and 5 % CO2. Cell viability was 
assessed through MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay as 
described previously [11,12]. 
The cytotoxicity on T98G cell line (human glioblastoma cells) was tested at Korea 
Institute of Science and Technology (KIST) Gangneung, Institute of Natural Product. The cell 
viability assay was performed by image analysis using calcein AM (staining for live cells) and 
propidium iodide (staining for dead cells). T98G cells were cultured in DMEM media (Hyclone 
Co.) mixed with 10 % fetal bovine serum (Gibco Co.), 1 % penicillin/streptomycin, and 4 mM 
L-glutamine using an incubator with 5 % CO2 at 37 
o
C. Cultured T98G cells were added in 96 
well plates at the density of 5  103 cells /well and grown for 24 hours. Compounds with various 
concentration and control (0.5 % of dimethyl sulfoxide) were added to cells. After incubating 
cells for 24 hours, media was removed and cells were washed with PBS. The cells were treated 
with calcein AM and PI, followed by incubation for 30 min. The cells were analyzed by operetta 
image analysis.  
Cholest-4-en-3,6-dione (5): Pyridiniumchlorochromate (PCC) (4.114 g, 19.0 mmol) was added 
to a solution of cholesterol (1.60 g, 3.8 mmol) in dry CH2Cl2 (30 mL) in one portion at room 
temperature. The reaction mixture was stirred at room temperature for 48 h. The solvent was 
removed under reduced pressure and the residue was redissolved in CH2Cl2 (30 mL) and then 
washed with cold distilled water and brine. After drying over anhydrous sodium sulfate, the 
solvent was removed under reduced pressure and the crude product was separated by 
chromatography on silica gel using dichloromethane/diethylether (1:1) as the eluent. Compound 
5 was obtained as pale yellow crystals (1.20 g, 80 %). 
1
H NMR (500 MHz, CDCl3) δH (ppm): 
6.18 (H-4), 2.69 (dd, J = 4.0, 11.0 Hz, H-2), 2.53 (m, 1H, H-7), 2.47 (m, 1H, H-7), 2.16 (m, 1H, 
H-1),  2.11 (m, 1H, H-12), 2.05 (dd, J = 16.0, 12.5 Hz, H-2), 1.93 (m, 1H, H-1), 1.91 (m, 1H, H-
20), 1.90 (m, 1H, H-16), 1.66 (m, 1H, H-11), 1.63 (m, 1H, 23), 1.53 (m, 2H, H-11, H-25), 1.40 
(m, 1H, H-8), 1.38 (m, 1H, H-9), 1.36 (m, 2H, H- 23, H-22), 1.33 (m, 1H, H-16), 1.31 (m, 1H, 
H-12), 1.18 (s, 3H, H-19), 1.15 (m, 4H, H-15, H-23, H-14, H-17), 1.12 (m, 1H, H-24), 1.03 (m, 
1H, H-22), 0.94 (d, J = 6.5 Hz, 3H, H-21), 0.88 (2d, J = 6.5 Hz, 6H, H-26, H-27), 0.74 (s, 3H, 
H-18).
13
C NMR (125 MHz, CDCl3), δC (ppm): 202.3 (C-3), 199.5 (C-6), 161.1 (C-5), 125.4 (C-
4), 56.6 (C-14), 56.0 (C-17), 51.0 (C-9), 46.8 (C-2), 42.5 (C-13), 39.8 (C-10), 39.45 (C-24), 39.1 
(C-12), 36.0 (C-22), 35.7 (C-8), 35.5 (C-1), 34.2 (C-20), 33.9 (C-7), 28.0 (C-25), 28.0 (C-16), 
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24.0 (C-15), 23.8 (C-23), 22.8 (C-26), 22.5 (C-27), 20.9 (C-11), 18.6 (C-21), 17.5 (C-19), 11.9 
(C-18).ESI-MS (m/z): 398.62 [M+H]
+
. 
(3E,6E)-dihydroximinocholest-4-ene (3): Compound 5 (81 mg, 0.2 mmol) and hydroxylamine 
hydrochloride (141 mg, 2.0 mmol) were dissolved in dry pyridine (5 mL). The mixture was 
stirred at room temperature for 24 h and the solvent was removed under reduced pressure. The 
residue was dissolved in water and extracted with ethyl acetate (3 x 10 mL). The organic layers 
were combined, dried over anhydrous Na2SO4, evaporated and the crude product was purified by 
chromatography on silica gel using dichloromethane/methanol (20:1) as the eluent to give 3 as a 
white solid (75 mg, 85%). 
1
H-NMR (CDCl3, 500 MHz) H (ppm): 6.53 (s, 1H, H-4), 3.33 (dd, 
1H, J = 4.5, 15.5 Hz, H-7), 3.08 (brd, 1H, J = 15.0 Hz, H-2), 1.00 (s, 3H, H-19), 0.91 (d, 3H, J = 
6.5 Hz, H-21), 0.87 (d, 3H, J = 2.0 Hz, H-26), 0.86 (d, 3H, J = 2.5 Hz, H-27), 0.69 (s, 3H, H-
18). 
13
C-NMR (CDCl3, 125 MHz) δC (ppm): 157.2 (C-6), 156.8 (C-3), 147.8 (C-5), 119.2 (C-4), 
56.7 (C-14), 56.1 (C-17), 51.3 (C-9), 42.6 (C-13), 39.5 (C-7, C-24), 38.3 (C-12), 36.1 (C-22), 
35.7 (C-20), 33.6 (C-1), 33.0 (C-10), 29.7 (C-8), 28.2 (C-16), 28.0 (C-25), 24.1 (C-23), 23.8 (C-
15), 22.8 (C-26), 22.6 (C-27), 21.3 (C-11), 18.7 (C-21), 18.6 (C-2), 17.6 (C-19), 11.9 (C-18). 
ESI-MS (m/z): 429.2 [M+H]
+
. 
Cholestane-3β,6α-diol (6):1M BH3 in THF (7 mL 7.0 mM) was added slowly to a solution of 
cholesterol (540 mg, 1.4 mM) in dry THF (8 mL) under argon atmosphere at 0 
o
C. The mixture 
was stirred at room temperature for 4h. Aqueous solution of NaOH (5 N, 1.5 mL) and 30 % 
H2O2 (0.75 mL) were added dropwise at 0 
o
C. The mixture was stirred at room temperature for 1 
h and then concentrated under reduced pressure. The residue was extracted with EtOAc (3×15 
mL). The combined organic layers were washed successively with 1N HCl, saturated NaHCO3 
solution and brine, dried over Na2SO4, filtered and evaporated in vacuo. The crude product was 
purified by chromatography on silica gel (DCM/MeOH 100:1) to yield 6 as white needles (402 
mg, 71 %). 
1
H NMR (500 MHz, CDCl3) δH (ppm): 3.55 (1H, m, H-3), 3.39 (1H, ddd, J = 4.5, 
10.5, 11.0 Hz, H-6), 0.90 (3H, d, J = 6.5 Hz, CH3-21), 0.86 (6H, d, J = 6.5 Hz, CH3-26, CH3-27), 
0.80 (3H, s, CH3-19), 0.65 (3H, s, CH3-18); 
13
C NMR (125 MHz, CDCl3) δC (ppm): 71.1 (C-3), 
69.4 (C-6), 56.2 (C-14), 56.18 (C-5), 53.8 (C-17), 51.6 (C-9), 42.6 (C-13), 41.5 (C-4), 39.8 (C-
12), 39.5 (C-24), 37.3 (C-1), 36.3 (C-10), 36.1 (C-22), 35.7 (C-20), 34.3 (C-8), 32.1 (C-7), 30.8 
(C-2 ), 28.1 (C-16), 28.0 (C-25), 24.2 (C-15), 23.8 (C-23), 22.8 (C-26), 22.5 (C-27), 21.1 (C-11), 
18.6 (C-19), 13.4 (C-21), 12.0 (C-18). 
Cholestane-3,6-dione (7): Solution of 6 (100 mg, 0.25 mmol) in CH2Cl2 (10 mL) was treated 
with PCC (280 mg, 1.25 mmol) in a similar procedure of 5 to give a crude product which was 
subjected to chromatography on silica gel (hexane/ethyl acetate, 19:1) to afford 7 (82 mg, 82%) 
as light yellow crystals. 
1
H-NMR (CDCl3, 500MHz) δH (ppm): 2.59 (brs, 1H, H-4),  2.40 (m, 1H, 
H-7), 2.37 - 2.34 (m, 1H, H-7), 2.30 - 2.32 (m, 1H, H-2), 2.05 - 2.10 (m, 1H, H-2), 2.00 (t, 1H, J 
= 12.0 Hz, H-4), 0.96 (s, 3H, H-19), 0.92 (d, 3H, J = 6.5 Hz, H-21), 0.87 (d, 3H, J = 6.5 Hz, H-
26), 0.86 (d, 3H, J = 6.5 Hz, H-27), 0.69 (s, 3H, H-18). ESI-MS (m/z): 401.2 [M+H]
+
. 
(3E,6E)-Dihydroximinocholestane (4): Compound 7 was prepared according to the procedure 
of 3. Compound 4 was obtained as off white needles (35 mg, 81 %). 
1
H-NMR (CDCl3, 500 
MHz) δH (ppm): 3.33 (dd, 1H, J = 4.5, 14.0 Hz, H-7), 3.27 (brd, 1H, J = 12.5 Hz, H-2), 0.91 
(d, 3H, J = 6.5 Hz, H-21), 0.87 (d, 3H, J = 6.0 Hz, H-26), 0.86 (d, 3H, J = 6.0 Hz, H-27), 0.85 (s, 
3H, H-19), 0.67 (s, 3H, H-18).
 13
C NMR (125 MHz, CDCl3) δC (ppm): 160.5 (C-6), 159.6 (C-3), 
56.6 (C-14), 56.2 (C-17), 54.0 (C-9), 50.9 (C-5), 42.9 (C-10), 39.7 (C-13), 39.5 (C-24, C-12), 
36.6 (C-22), 36.1 (C-20), 35.7 (C-8), 35.6 (C-16), 29.5 (C-25), 28.3 (C-7), 28.1 (C-2), 28.0 (C-
1), 24.1 (C-19), 23.8 (C-15), 22.8 (C-23), 22.5 (C-4), 21.4 (C-27), 19.9 (C-26), 18.6 (C-11), 12.1 
(C-21), 11.8 (C-18). ESI-MS (m/z): 431.2 [M+H]
+
. 
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Cholest-4-ene-3β,6α-diol (8): The solution of 5 (530 mg, 1.38 mmol) in 20 mL of the solvent 
mixture (CH2Cl2:MeOH, 1:1) was stirred at room temperature. CeCl3.7H2O (530 mg, 1.38 
mmol) and NaBH4 (232 mg, 6.07 mmol) were added to the solution and the mixture was stirred 
for 1h. The HCl aqueous solution (1N) was added dropwise to neutralize the alkaline medium. 
CH2Cl2 (15 mL) was added and the organic layer was separated and dried over Na2SO4. The 
solvent was removed in vacuo to yield a white solid which was purified by flash column 
chromatography on silica gel (n-hexane/EtOAc, 5:1) to give 8 as white needles (580 mg, 89%). 
1
H NMR (500 MHz, CDCl3), δH (ppm): 5.65 (H-4), 4.22 (m, H-3), 4.19 (m, H-6), 1.04 (s, 3H, H-
19), 0.90 (d, J = 6.0 Hz, 3H, H-21), 0.865 (d, J = 7.0 Hz, 3H, H-26), 0.860 (d, J = 6.5 Hz, 3H, H-
27), 0.68 (s, 3H, H-18). 
13
C NMR (125 MHz, CDCl3), δC (ppm): 149.2 (C-5), 119.8 (C-4), 68.6 
(C-3), 67.9 (C-6), 56.2 (C-14), 55.8 (C-17), 54.2 (C-9), 42.5 (C-13), 42.1 (C-2), 39.7 (C-10), 
39.5 (C-24), 37.9 (C-12), 36.1 (C-22), 36.0 (C-8), 35.8 (C-1), 34.4 (C-20), 29.0 (C-7), 28.1 (C-
25), 28.0 (C-16), 24.2 (C-15), 23.8 (C-23), 22.8 (C-26), 22.5 (C-27), 21.0 (C-11), 19.7 (C-21), 
18.7 (C-19), 12.0 (C-18). 
6-hydroxy-4α,5α-epoxycholestane-3-one (9) and 4α,5α-epoxycholestane-3,6-dione (10): 
Compound 8 (285 mg, 0.7 mmol) in CH2Cl2 (20 mL) was treated with m-CPBA (290 mg, 1.48 
mmol) in CH2Cl2 (10 mL) by the procedure of 6 to give a mixture of 4α,5α-epoxy-cholestane-
3β,6α-diol and 4β,5β-epoxy-cholestane-3β,6α-diol (250 mg, 4:1).To a stirred solution of the diol 
mixture (210 mg) in 10 mL of CH2Cl2 at 0 
o
C was added Dess-Martin periodinane (420 mg, 0.96 
mmol). After 1 h, the homogeneous solution was diluted with diethylether (10 mL) and poured 
into saturated aqueous NaHCO3 (20 mL) containing Na2S2O3 (4 g). The mixture was stirred for 
15 min. The organic layers were separated and extracted with ether 10 mL. The organic phase 
was washed with saturated NaHCO3 (30 mL) and water (30 mL), dried, filtered, and 
concentrated in vacuo. The residue was purified by flash column chromatography (silica gel, n-
hexane/EtOAc, 9:1) to give 9 (36 mg, 12.3 %) and 10 (60 mg, 14.5 %). 
6-hydroxy-4α,5α-epoxycholestane-3-one (9): white needles. 1H-NMR (CDCl3, 500 MHz), δH 
(ppm): 4.17 (dd, 1H, J 3.0 & 10.0Hz, H-6), 3.48 (s, 1H, H-4), 1.13 (s, 3H, H-19), 0.90 (d, 3H, J 
= 6.5Hz, H-21), 0.87 (d, 3H, J = 6.0Hz, H-26), 0.86 (d, 3H, J = 6.0Hz, H-27), 0.69 (s, 3H, H-
18). 
13
C-NMR (CDCl3, 125 MHz), δC (ppm): 206.0 (C=O, C-3), 72.4 (C-5), 64.7 (C-6), 56.7 (C-
4), 56.1 (C-14), 55.6 (C-17), 46.3 (C-9), 42.8 (C-13), 39.5 (C-2), 39.4 (C-24), 38.2 (C-12), 37.5 
(C-10), 36.1 (C-22), 35.7 (C-8), 34.1 (C-20), 32.6 (C-1), 28.0 (C-25, C-7), 28.01 (C-16), 26.6 
(C-15), 24.2 (C-15), 23.8 (C-23), 22.8 (C-27), 22.6 (C-26), 21.6 (C-11), 19.2 (C-19), 18.6 (C-
21), 12.0 (C-18). ESI-MS (m/z):  417.2 [M+H]
+
. 
4α,5α-epoxycholestane-3,6-dione (10): white needles.1H-NMR (CDCl3, 500 MHz), δH (ppm): 
3.13 (s, 1H, H-4), 1.15 (s, 3H, H-19), 0.92 (d, 3H, J = 6.5 Hz, H-21), 0.87 (d, 3H, J = 6.5 Hz, H-
26), 0.86 (d, 3H, J = 6.5 Hz, H-27), 0.72 (s, 3H, H-18).
13
C-NMR (CDCl3, 125 MHz), δC (ppm): 
203.2 (C=O, C-6), 202.8 (C=O, C-3), 71.4 (C-5), 60.1 (C-4), 56.4 (C-17), 56.0 (C-14), 46.15 (C-
2), 46.13 (C-9), 42.9 (C-13), 39.5 (C-24), 39.11 (C-12), 39.07 (C-10), 36.1 (C-22), 35.7 (C-8), 
35.6 (C-20), 32.5 (C-7), 28.0 (C-25), 27.9 (C-16), 27.6 (C-1), 24.0 (C-15), 23.8 (C-23), 22.8 (C-
27), 22.6 (C-26), 21.7 (C-11), 18.7 (C-19), 18.6 (C-21), 12.0 (C-18). ESI-MS (m/z): 415.2 
[M+H]
+
. 
4α,5α-epoxy-6-hydroxycholestane-3-oxime (11) and4,5,6-trihydroxy cholestane-3-one (12): 
6-hydroxy-4α,5α-epoxycholestane-3-one (9) (25 mg, 0.06 mmol) was treated with 
hydroxylamine hydrochloride (NH2OH.HCl) (60 mg, 0.7 mmol) in pyridine (3 mL) by the 
procedure of 3 to give a residue which was subjected to column chromatography on silica gel (n-
hexane/EtOAc, 3:1) to give 11 (5 mg, 19.3 %) and 12 (3.5 mg, 13.4 %). 
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4α,5α-epoxy-6-hydroxycholestane-3-oxime (11): white needles. 1H-NMR (CDCl3, 500 MHz), 
δH (ppm): 4.16 (dd, 1H, J = 5.0, 11.5 Hz, H-6β), 3.81 (1H, s, H-4), 2.59 (dd, 1H, J = 4.0, 19.5 
Hz, H-8), 1.06 (s, 3H, H-19), 0.90 (d, 3H, J = 6.0 Hz, H-21), 0.86 (2d, 6H, J = 1.5, 6.0 Hz, H-26, 
27), 0.68 (s, 3H, H-18).
13
C-NMR (CDCl3, 125 MHz), δC (ppm): 154.9 (C-3), 89.7 (C-5), 69.5 
(C-4), 64.8 (C-6), 56.2 (C-14), 55.6 (C-17), 54.2 (C-9), 45.7 (C-2), 42.8 (C-13), 39.5 (C-10), 
39.4 (C-24), 38.0 (C-12), 37.4 (C-22), 36.1 (C-1), 35.8 (C-8), 34.1 (C-7), 28.1 (C-25), 28.0 (C-
16), 25.7 (C-20), 24.2 (C-15), 23.8 (C-23), 22.8 (C-26), 22.6 (C-27), 21.5 (C-11), 18.6 (C-21), 
17.9 (C-19), 12.0 (C-18). (+)-HR-ESI-MS: 432.3474 [M+H]
+ 
(calculated for C27H46NO3: 
432.3478). 
4,5,6-trihydroxy cholestane-3-one (12): white needles.
1
H-NMR (CDCl3, 500 MHz), δH (ppm): 
4.05 (m, 1H, H-6), 3.28 (d, 1H, J = 3.5 Hz, H-4), 2.60 (dd, 1H, J = 3.5 & 15.0Hz, H-7), 2.08 (d, 
1H, J = 3.0 Hz, H-12), 2.06 (d, 1H, H-24), 1.96 (t, 1H, J = 12.5 Hz, H-7), 1.89 (m, 1H, H-8), 
1.87 (m, 1H, H-25), 1.64 (m, 1H, H-2), 1.56 (m, H-15), 1.53 (m, H-2), 1.52 – 1.50 (m, 2H, H-
11), 1.03 (s, 3H, H-19), 0.92 (d, 3H, J = 6.5 Hz, H-21), 0.87 (d, 3H, J = 6.5 Hz, H-26), 0.86 (d, 
3H, J = 6.0 Hz, H-27), 0.70 (s, 3H, H-18). 
13
C-NMR (CDCl3, 125 MHz), δC (ppm): 205.6 (C=O, 
C-3), 69.9 (C-5), 64.7 (C-6), 62.6 (C-4), 56.5 (C-14), 56.1 (C-17), 48.1 (C-9), 46.5 (C-7), 42.7 
(C-13), 39.5 (C-12), 39.3 (C-24), 38.1 (C-10), 36.1 (C-22), 35.7 (C-20), 34.8 (C-8), 29.2 (C-1), 
28.01 (C-23), 28.0 (C-25), 25.7 (C-2), 24.1 (C-15), 23.8 (C-16), 22.8 (C-26), 22.6 (C-27), 21.5 
(C-11), 18.6 (C-21), 18.3 (C-19), 11.9 (C-18). (+)-HR-ESI-MS: [M+H]
+
 435.3633 (calculated 
for C27H47O4: 435.3474). 
4α,5α-epoxycholestane-3,6-dioxime (13): 4α,5α-epoxycholestane-3,6-dione 30 mg (10, 0.07  
mmol) was treated with hydroxylamine hydrochloride (50 mg, 0.7 mmol) in pyridine (3 mL) by 
the procedure of 3 to give a crude product which was subjected to chromatography on silica gel 
(DCM/EtOAc, 6:1) to give 13 as white needles (7.0 mg, 22.5 %).
1
H NMR (CDCl3, 500 MHz), 
δH (ppm): 4.44 (s, 1H, H-4), 2.64 (m, 1H, H-7), 2.58 (m, 1H, H-2), 2.40 (dd, 1H, J = 5.0, 19.5 
Hz, H-2), 2.14 (m, 1H, H-7), 2.10 (m, 1H, H-8), 2.00 (dt, 1H, J = 3.5, 6.0 Hz, H-12), 1.86 (m, 
1H, H-9), 0.91 (d, 3H, J = 6.5 Hz, H-21), 0.88 (d, 3H, J = 6.5 Hz, H-26), 0.87 (s, 3H, H-19), 
0.86 (d, 3H, J = 6.5 Hz, H-27), 0.69 (s, 3H, H-18).
13
C-NMR (CDCl3, 125 MHz), δC (ppm): 161.3 
(C=NOH, C-6), 154.6 (C=NOH, C-3), 91.0 (C-5), 85.7 (C-4), 57.5 (C-14), 55.9 (C-17), 49.0 (C-
9), 42.4 (C-13), 40.7 (C-10), 39.5 (C-12, C-24), 39.3 (C-2), 36.1 (C-22), 35.7 (C-8), 32.1 (C-20), 
30.4 (C-23), 28.0 (C-7), 27.97 (C-25), 27.8 (C-16), 24.2 (C-15), 23.8 (C-23), 22.8 (C-2), 22.54 
(C-27), 22.47 (C-26), 19.4 (C-11), 18.7 (C-21), 14.8 (C-19), 11.8 (C-18). (+)-HR-ESI-MS: 
[M+H]
+
 445.3427 (calculated for C27H45N2O3: 445.3430). 
3. RESULTS AND DISCUSSION 
Two known steroidal oximes (3, 4) with two hydroximino groups at C-3 and C-6 were 
prepared from cholesterol as starting material by methods described by Cui et al. (Figure 2) [7, 
8]. 
Oxidation of cholesterol with pyridinium chlorochromate (PCC) in CH2Cl2 gave compound 
4-en-3,6-dione (5) with 80 % yield. Next, the dione 5 was treated with hydroxylamine 
hydrochloride in pyridine to afford the dihydroxyimino with a double bondat C-4,5 position in 3 
(85 %). The structure of 5 and 3 were confirmed by analysis of 
1
H, 
13
C NMR, ESI-MS spectra 
and by comparing with reported data [7]. Reduction of cholesterol to 3,6-diol 6 by using BH3 in 
THF, then treated with H2O2/NaOH. Oxime derivative 4 was prepared from diol 6 by two 
synthetic steps as in the case of 3 in a yield of 82 % and 81 %, respectively [8].    
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Figure 2. Reagents and conditions: (i): PCC/CH2Cl2, rt, 48 h; (ii): NH2OH.HCl/Pyridine, rt, 24 h;                     
(iii): BH3.THF/H2O2, NaOH, rt, 1 h. 
 
Figure 3. Reagents and conditions: (i): CeCl3.7H2O/NaBH4, CH2Cl2&MeOH, rt, 1 h; (ii): 1. m-
CPBA/CH2Cl2, 0 
o
C then rt, 4 h; 2. Dess-Martin/CH2Cl2, 0
 o
C, 1 h; (iii): NH2OH.HCl/Pyridine, rt, 24 h. 
Two new steroidal oximes 11 and 13, with an epoxide ring at C-3,4, were prepared in 3 
steps from diketone 5 according to the sequence shown in Figure 3. First, the reduction of 5 
using NaBH4 in the presence of CeCl3.7H2O gave the cholest-4-en-3,6-diol (8) in 89 % yield. 
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The signals of C=O groups at δC 202.3 and 199.5 ppm in the 
13
C NMR spectrum of 5 were 
replaced by two characteristic signals of CH-OH groups at δC 68.6 (C-3) and 67.9 (C-6) in the 
13
C NMR spectrum of 8. The α-configuration of H-3 and β-configuration of H-6 of compound 8 
was comfirmed by comparing the coupling constance, chemical shifts and multiplicities with 
reported data by Cui [13]. Oxidation of  8 with m-CPBA and then by Dess-Martin in 
dichloromethane at 0 
o
C for 1 h gave the mixture of 6-hydroxy-4α,5α-epoxycholestane-3-one (9) 
and 4α,5α-epoxycholestane-3,6-dione (10). 13C NMR spectra of 9 and 10 revealed that 
compound 9 was incomplete oxidation product with only one group carbonyl at C-3 (δC 206.0) 
and compound 10 contained two carbonyl group at C-3 (δC 203.2) and C-6 (δC 202.8). It was 
indicated that 8 was first converted to a mixture of 4α,5α-epoxide-3,6-diol and 4β,5β-epoxide-
3,6-diol (TLC analysis monitoring) under treatment with m-CPBA [9], and then the CH-OH 
groups at C-3 and C-6 were oxidized by Dess Martin reagent into C=O group. It was surprising 
that only oxidative products from 4α,5α-epoxide were observed from the results reactional 
medium. NOESY spectra of 9 and 10 with the correlation between H-4 and H-19 confirmed -
configuration of epoxide ring in two molecules. 
Similar procedure as above using hydroxylamine hydrochloride in pyridine on compound 9 
and 10 afforded corresponding hydroximino products 11 and 13. The 
1
H NMR spectrum of 
compound 11 showed all proton signals as in the 
1
H NMR spectrum of 9, but with a deshielding 
of H-4 signal from δH 3.48 to δH 3.81 ppm. Likewise, the carbonyl group’s resonance signal (C-
3) of compound 9 at δC 206.0 ppm disappeared and replaced by a quaternary carbon at δC 154.9 
(C-3) which assigned to the C=N-OH groups of the expected product. Moreover, the carbon C-4 
and C-5 signals of compound 11 move slightly towards the lower field comparing to compound 
9. Similarly, in the 
13
C NMR specctrum of product 13, the presence of two quaternary carbon 
signals at δC 154.6 (C-3) and 161.3 (C-6) confirmed that 2 C=O groups of 10 were converted to 
C=N-OH groups. Additionally, HRMS data of 11 and 13 correspond to expected molecular 
formulas. A side-product by the epoxide opening reduction (12) was suprisingly obtained 
together with 13 from the reaction of 9. 
13
C NMR spectrum of 12 showed the presence of one 
C=O group (δC 205.6) and three C-OH groups (δC 69.9 (C-5), 64.7 (C-6) and 62.6 (C-4)).  
Biological evaluation: Cytotoxicity of prepared hydroximinosteroidal derivatives (3, 4, 11, 13) 
and their intermediates (5-10, 12) against three human cancer cell lines including hepatocellular 
carcinoma (Hep-G2), cervical cancer (HeLa) and glioblastoma (T98G) were studied. The results 
which were expressed as IC50 values in µM revealed that compounds 3, 4, 9, 10, 12 and 13 
exhibited a moderate activity against at least one tested cancer cell line at concentrations of up to 
50 µg/mL (Table 1). In particular, hydroximinosteroidal 13 shows a potent antiproliferative 
effect to T98G cancer cells at 2.9 M of IC50. 
Apparently, among the hydroximinosteroidal derivatives  (3, 4, 11, 13), compounds with 
oxime group at C-6 (3, 4, 13) exhibited stronger cytotoxicity against 3 tested cancer cell lines 
compare to compound with only oxime group at C-3 (11). However, the absence of 4,5-double 
bond on3,6-dihydroximino 4 caused loss of cytotoxic activity against Hela and Hep-G2 cell lines 
in comparison of 3,6-dihydroximino 3. Cui et al. previously also observed the decrease of 
cytotoxicity of 4 in comparison of 3 while testing against Sk-Hep-1, H-292, PC-3 and Hey-1B 
cancer cell lines [7, 8]. It was interesting that compound 11 with only 3-hydroximino group and 
4,5-epoxide ring was found inactive, while 3,6-dihydroxyimino 13 with 4,5-epoxide ring was 
selectively cytotoxic against T98G  (IC50: 2.9 µM). 
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Table 1. Cytotoxic activity of synthetic compounds against three human cancer cell lines. 
 
Compounds Structure 
IC50 (µM)  
HeLa Hep-G2 T98G 
3 
 
68.6 42.4 70.3 
4 
 
>100 >100 69.8 
11 
 
>100 >100 >100 
13 
 
>100 >100 2.9 
5 
 
>100 >100 >100 
6 
 
>100 >100 >100 
7 
 
>100 >100 >100 
8 
 
>100 >100 >100 
9 
 
72.4 41.8 >100 
10 
 
74.6 > 100 >100 
12 
 
>100 >100 18.5 
Paclitaxel
a
  0.031 0.040 0.023 
a
 Used as positive control. Hela: cervical cancer cell line; Hep G2: hepatocellular carcinoma cell line; 
T98G: glioblastoma cell line. Paclitaxel: positive control. 
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Among the intermediates (6-10, 12), the results demonstrated that compounds with the 
presence of oxygen at C-4 or C-5 (9, 10, 12) showed a moderate cytotoxic activity against at 
least one of tested cell lines whereas the others were found no obvious cytotoxicity against these 
cancer cells. These results coincide with previously reported researches, have revealed that the 
hydroximino group at C-6 is important for determination of cytotoxic activity of this type of 
compound. The 4,5-double bond or oxygen at C-4 or C-5 may have positive effects on 
cytotoxicity against tested cancer cells [8, 9]. This study gave supplement information for the 
structure – activity relationship and need further investigation. 
Preliminary antimicrobial assays indicated that six of tested compounds, i.e.  5, 6, 9, 10, 11, 
13, were active against at least one microorganism strain with MIC values ranging between                
12.5 - 50 g/mL (Table 2). Two new oximes 11 and 13 were found active against E. coli and       
S. aureus strain. 
Table 2. Antimicrobial activity of compounds 3-13. 
 
Compounds 
Minimum inhibitory 
concentration (MIC, µg/ml) 
 
Compounds 
MIC (µg/ml) 
E
. 
co
li
 
P
.a
er
u
g
in
o
sa
 
B
. 
su
b
ti
ll
is
 
S
. 
a
u
re
u
s 
E
. 
co
li
 
P
. 
a
er
u
g
in
o
sa
 
B
. 
su
b
ti
ll
is
 
S
. 
a
u
re
u
s 
3 >50 > 50 > 50 > 50 9 50 > 50 > 50 > 50 
4 > 50 > 50 > 50 > 50 10 25 > 50 > 50 > 50 
5 50 > 50 > 50 >50 11 50 > 50 > 50 50 
6 > 50 > 50 > 50 50 12 >50 > 50 > 50 > 50 
7 > 50 > 50 > 50 > 50 13 50 > 50 > 50  50 
8 > 50 > 50 > 50 > 50 Positive 
control 
0.06-0.1 
(Doxycycline) 
0.5-0.9 
(Gentamicin) 
4. CONCLUSIONS 
Two new hydroximino steroid derivatives of cholesterol (11, 13) with 1-2 hydroximino 
groups at C-3 (ring A) and C-6 (ring B), and with epoxide ring at C-4,5 were prepared by short 
and efficient synthetic pathway. The cytotoxicity against HepG2, Hela and T98G of synthesized 
compounds and their intermediates together with 2 known hydroximinosteroids (3, 4) were 
studied for the first time. Compound 13 presented a potent antiproliferative effect to T98G 
cancer cell with IC50 value of 2.9 M. In addition, two new oximes 11 and 13 and compounds 5, 
6, 9, 10 were shown active in antimicrobial assay against at least one tested strain with MIC 
values ranging between 12.5 - 50 g/mL. 
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